{"id":"W3022306844","doi":"10.1016/j.cjco.2020.04.007","title":"Canadian Real-World Experience of Using Sacubitril/Valsartan in Patients With Heart Failure With Reduced Ejection Fraction: Insight From the PARASAIL Study","year":2020,"lang":"en","type":"article","venue":"CJC Open","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"Novartis (Canada); Saint John Regional Hospital; University of British Columbia; Institut universitaire de cardiologie et de pneumologie de Québec; University of Saskatchewan","funders":"Bayer Canada; Pfizer Canada; Novartis Pharmaceuticals Canada; Bristol-Myers Squibb Canada; Amgen; Boehringer Ingelheim; Roche; Novartis; Servier; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb; Merck","keywords":"Ejection fraction; Sacubitril, Valsartan; Valsartan; Cardiology; Heart failure; Internal medicine; Sacubitril; Fraction (chemistry); Medicine; Chemistry; Blood pressure; Chromatography","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002672677,0.0003851888,0.0006441664,0.0003836451,0.001552266,0.001072983,0.0007371068,0.0004531414,0.002411165],"category_scores_gemma":[0.00490809,0.0001760067,0.0006093215,0.001437201,0.0007221513,0.000331903,0.000567683,0.0007203855,0.0002289402],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01203769,"about_ca_system_score_gemma":0.01637478,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.7749257,"about_ca_topic_score_gemma":0.8922333,"domain_scores_codex":[0.9973817,0.0006033895,0.000110876,0.0002068486,0.001332598,0.0003644893],"domain_scores_gemma":[0.9947531,0.000746406,0.00132731,0.0001869036,0.00176004,0.001226233],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01498458,0.001675019,0.8559156,0.0009866641,0.0009610151,0.0006888581,0.002614286,0.001228244,0.002618331,0.0006335708,0.0107147,0.1069792],"study_design_scores_gemma":[0.001504199,0.002437,0.9787579,0.0001259215,0.0005057235,0.0004260004,0.001400488,0.0007721584,0.0005220021,0.00007756912,0.01335843,0.0001126011],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9821327,0.004366778,0.0001982124,0.001340159,0.00003354578,0.0002650246,0.002890762,0.00001718217,0.008755444],"genre_scores_gemma":[0.9943544,0.002103404,0.0006023375,0.0004734483,0.00005322537,0.00005125501,0.001788193,0.000008148018,0.0005656328],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2250743,"threshold_uncertainty_score":0.4527996,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03456976512409696,"score_gpt":0.3034481326511999,"score_spread":0.2688783675271029,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}